Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Nov 13;108(2):djv323. doi: 10.1093/jnci/djv323

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

PMC Copyright notice

Figure 2. — Kaplan-Meier survival curves for TET2-specific differentially methylated CpGs (tet2-DMC)-low (blue) and -high (red) patients in the combined cohorts. Tet2-DMC–low patients showed statistically longer overall survival (OS) compared with tet2-DMC–high in the analysis with all patients (A) in the intermediate-risk cytogenetics group (B) and the poor-risk cytogenetics group (C). D) Kaplan-Meier survival curves for OS adjusted based on bone marrow transplantations censoring and recurrence-free survival are shown in the upper and lower rows, respectively, in the analysis with all patients (left column), in the intermediate-risk cytogenetics group (center column), and the poor-risk cytogenetics group (right column), respectively. P values are derived from two-sided log-rank test. OS BMT = overall survival adjusted for bone marrow transplantations censoring; RFS = recurrence-free survival.